Liver Failure/Cirrhosis/Portal Hypertension

You have full text access to this OnlineOpen article

Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation†

  1. Alexander Dechêne1,
  2. Jan-Peter Sowa1,
  3. Robert K. Gieseler1,4,
  4. Christoph Jochum1,
  5. Lars P. Bechmann1,5,
  6. Amr El Fouly1,
  7. Martin Schlattjan1,
  8. Fuat Saner2,
  9. Hideo A. Baba3,
  10. Andreas Paul2,
  11. Volker Dries6,
  12. Margarethe Odenthal7,
  13. Guido Gerken1,
  14. Scott L. Friedman5,
  15. Ali Canbay1,‡,*

Article first published online: 14 MAY 2010

DOI: 10.1002/hep.23754

Issue

Hepatology

Hepatology

Volume 52, Issue 3, pages 1008–1016, September 2010

Additional Information

How to Cite

Dechêne, A., Sowa, J.-P., Gieseler, R. K., Jochum, C., Bechmann, L. P., El Fouly, A., Schlattjan, M., Saner, F., Baba, H. A., Paul, A., Dries, V., Odenthal, M., Gerken, G., Friedman, S. L. and Canbay, A. (2010), Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. Hepatology, 52: 1008–1016. doi: 10.1002/hep.23754

Author Information

  1. 1

    Department of Gastroenterology and Hepatology, Essen, Germany

  2. 2

    Department of General, Visceral, and Transplantation Surgery, Essen, Germany

  3. 3

    Institute for Pathology and Neuropathology, University Hospital Essen, Essen, Germany

  4. 4

    Division of Research and Development, Rodos BioTarget, Medical Park Hannover, Hannover, Germany

  5. 5

    Department of Liver Diseases, Mount Sinai School of Medicine, New York, NY

  6. 6

    Institute of Pathology, Mannheim, Germany

  7. 7

    Institute of Pathology, University Hospital Cologne, Cologne, Germany

  1. ‡

    fax: +49 (201) 723-5719

*Department of Gastroenterology and Hepatology, University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 26 AUG 2010
  2. Article first published online: 14 MAY 2010
  3. Manuscript Accepted: 30 APR 2010
  4. Manuscript Received: 16 MAR 2010

Funded by

  • German Research Foundation. Grant Number: CA 267/6-1
  • Wilhelm Laupitz Foundation

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (557K)

References

  • 1
    O'Grady JG. Acute liver failure. Postgrad Med J 2005; 81: 148–154.
  • 2
    Lee WM, Squires RH, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. HEPATOLOGY 2008; 47: 1401–1415.
    Direct Link:
  • 3
    Rutherford A, Chung RT. Acute liver failure: mechanisms of hepatocyte injury and regeneration. Semin Liver Dis 2008; 28: 167–174.
  • 4
    Riordan SM, Williams R. Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure. Semin Liver Dis 2003; 23: 203–215.
  • 5
    Canbay A, Friedman S, Gores GJ. Apoptosis: the nexus of liver injury and fibrosis. HEPATOLOGY 2004; 39: 273–278.
    Direct Link:
  • 6
    Wirz W, Antoine M, Tag CG, Gressner AM, Korff T, Hellerbrand C, et al. Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells. Differentiation 2008; 76: 784–794.
    Direct Link:
  • 7
    Parola M, Marra F, Pinzani M. Myofibroblast-like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario. Mol Aspects Med 2008; 29: 58–66.
  • 8
    Bechmann LP, Marquitan G, Jochum C, Saner F, Gerken G, Canbay A. Apoptosis versus necrosis rate as a predictor in acute liver failure following acetaminophen intoxication compared with acute-on-chronic liver failure. Liver Int 2008; 28: 713–716.
  • 9
    Singhal S, Jain S, Kohaar I, Singla M, Gondal R, Kar P. Apoptotic mechanisms in fulminant hepatic failure: potential therapeutic target. Appl Immunohistochem Mol Morphol 2009; 17: 282–285.
  • 10
    Guo J, Friedman SL. Hepatic fibrogenesis. Semin Liver Dis 2007; 27: 413–426.
  • 11
    Consolo M, Amoroso A, Spandidos DA, Mazzarino MC. Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease. Int J Mol Med 2009; 24: 143–152.
  • 12
    Hemmann S, Graf J, Roderfeld M, Roeb E. Expression of MMPs and TIMPs in liver fibrosis—a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 2007; 46: 955–975.
  • 13
    Iimuro Y, Brenner DA. Matrix metalloproteinase gene delivery for liver fibrosis. Pharm Res 2008; 25: 249–258.
  • 14
    Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, Gores GJ. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest 2003; 83: 655–663.
  • 15
    Sagir A, Erhardt A, Schmitt M, Häussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. HEPATOLOGY 2008; 47: 592–595.
    Direct Link:
  • 16
    Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. HEPATOLOGY 2008; 47: 380–384.
    Direct Link:
  • 17
    Taylor B. Implementation and clinical audit of alcohol detoxification guidelines. Br J Nurs 2006; 15: 30–37.
  • 18
    Bower WA, Johns M, Margolis HS, Williams IT, Bell BP. Population-based surveillance for acute liver failure. Am J Gastroenterol 2007; 102: 2459–2463.
    Direct Link:
  • 19
    Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 2002; 123: 1323–1330.
  • 20
    Feldstein AE, Papouchado BG, Angulo P, Sanderson S, Adams L, Gores GJ. Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2005; 3: 384–389.
  • 21
    Volkmann X, Anstaett M, Hadem J, Stiefel P, Bahr MJ, Lehner F, et al. Caspase activation is associated with spontaneous recovery from acute liver failure. HEPATOLOGY 2008; 47: 1624–1633.
    Direct Link:
  • 22
    Fausto N, Campbell JS, Riehle KJ. Liver regeneration. HEPATOLOGY 2006; 43( Suppl 1): S45–S53.
    Direct Link:
  • 23
    Desbarats J, Newell MK. Fas engagement accelerates liver regeneration after partial hepatectomy. Nat Med 2000; 6: 920–923.
  • 24
    El-Gindy I, El Rahman ATA, El-Alim MA, Zaki SSA. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease. Egypt J Immunol 2003; 10: 27–35.
  • 25
    el-Shorbagy E, Afefy AF, Ibrahem IA, Mangoud AM, Eissa MH, Sabee EI, et al. Non-invasive markers and predictors of severity of hepatic fibrosis in HCV patients at Sharkia Governorate, Egypt. J Egypt Soc Parasitol 2004; 34( Suppl): 459–478.
  • 26
    Lichtinghagen R, Huegel O, Seifert T, Haberkorn CI, Michels D, Flemming P, et al. Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C. Clin Chem 2000; 46: 183–192.
  • 27
    Kisseleva T, Brenner DA. Hepatic stellate cells and the reversal of fibrosis. J Gastroenterol Hepatol 2006; 21( Suppl 3): S84–S87.
    Direct Link:
  • 28
    Gieling RG, Burt AD, Mann DA. Fibrosis and cirrhosis reversibility—molecular mechanisms. Clin Liver Dis 2008; 12: 915–937.
  • 29
    Friedman SL, Bansal MB. Reversal of hepatic fibrosis—fact or fantasy? HEPATOLOGY 2006; 43( Suppl 1): S82–S88.
    Direct Link:
  • 30
    Das SK, Vasudevan DM. Genesis of hepatic fibrosis and its biochemical markers. Scand J Clin Lab Invest 2008; 68: 260–269.
  • 31
    Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209–218.
  • 32
    Skripenova S, Trainer TD, Krawitt EL, Blaszyk H. Variability of grade and stage in simultaneous paired liver biopsies in patients with hepatitis C. J Clin Pathol 2007; 60: 321–324.
  • 33
    Foucher J, Chanteloup E, Vergniol J, Castéra L, Le Bail B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55: 403–408.
  • 34
    Takemoto R, Nakamuta M, Aoyagi Y, Fujino T, Yasutake K, Koga K, et al. Validity of FibroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infection. J Dig Dis 2009; 10: 145–148.
    Direct Link:
  • 35
    Hartland SN, Murphy F, Aucott RL, Abergel A, Zhou X, Waung J, et al. Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin. Liver Int 2009; 29: 966–978.
    Direct Link:
  • 36
    Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 2006; 130: 435–452.
  • 37
    Jeong W, Park O, Radaeva S, Gao B. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. HEPATOLOGY 2006; 44: 1441–1451.
    Direct Link:
  • 38
    Wei G, Bergquist A, Broomé U, Lindgren S, Wallerstedt S, Almer S, et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med 2007; 262: 393–401.
    Direct Link:
View Full Article with Supporting Information (HTML) Get PDF (557K)